Risk of ischemic stroke after cancer diagnosis: a population-based matched cohort study

IF 5 2区 医学 Q1 HEMATOLOGY Journal of Thrombosis and Haemostasis Pub Date : 2025-04-01 DOI:10.1016/j.jtha.2024.12.029
Deborah M. Siegal , Joshua O. Cerasuolo , Marc Carrier , Peter L. Gross , Moira K. Kapral , David Kirkwood , Ronda Lun , Michel Shamy , Rinku Sutradhar
{"title":"Risk of ischemic stroke after cancer diagnosis: a population-based matched cohort study","authors":"Deborah M. Siegal ,&nbsp;Joshua O. Cerasuolo ,&nbsp;Marc Carrier ,&nbsp;Peter L. Gross ,&nbsp;Moira K. Kapral ,&nbsp;David Kirkwood ,&nbsp;Ronda Lun ,&nbsp;Michel Shamy ,&nbsp;Rinku Sutradhar","doi":"10.1016/j.jtha.2024.12.029","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>There are limited data regarding the association between cancer and ischemic stroke, particularly among individuals with previous stroke.</div></div><div><h3>Objective</h3><div>Our objective was to measure and compare the risk of ischemic stroke in individuals with and without cancer.</div></div><div><h3>Methods</h3><div>Population-based matched cohort study in Ontario, Canada. Participants aged ≥18 years with a new diagnosis of cancer were matched (1:1) to cancer-free controls by age and sex in 2 separate matched cohorts based on the absence (matched cohort 1) or presence (matched cohort 2) of prior ischemic stroke. The primary outcome was the incidence of ischemic stroke. We calculated subdistribution adjusted hazard ratios (aHR) and 95% CIs for ischemic stroke (death as a competing event).</div></div><div><h3>Results</h3><div>In matched cohort 1, the rate and risk of ischemic stroke were higher among 620,647 patients with cancer versus 620,647 controls at 1.5 years (4.6/1000 person-years [95% CI, 4.5-4.7] vs 3.5/1000 person-years [95% CI, 3.4-3.6]; aHR, 1.40; 95% CI, 1.34-1.47). In matched cohort 2, the rate and risk of ischemic stroke were similar among 13,924 patients with cancer and 13,924 controls at 1.5 years (26.9/1000 person-years [95%CI 25.1-28.9] vs 22.0 /1000 person-years [95% CI, 20.7-23.4]; aHR, 1.00; 95% CI, 0.88-1.14). In both cohorts, the risk of ischemic stroke was lower in patients with cancer versus controls from 1.5 to 5 years (aHR, 0.72; 95% CI, 0.69-0.74 and aHR, 0.53; 95% CI, 0.46-0.62).</div></div><div><h3>Conclusions</h3><div>Compared with cancer-free controls, the rate and risk of ischemic stroke were higher 1.5 years after cancer diagnosis in individuals without prior stroke and varied according to cancer site and stage.</div></div>","PeriodicalId":17326,"journal":{"name":"Journal of Thrombosis and Haemostasis","volume":"23 4","pages":"Pages 1269-1277"},"PeriodicalIF":5.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1538783624007785","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

There are limited data regarding the association between cancer and ischemic stroke, particularly among individuals with previous stroke.

Objective

Our objective was to measure and compare the risk of ischemic stroke in individuals with and without cancer.

Methods

Population-based matched cohort study in Ontario, Canada. Participants aged ≥18 years with a new diagnosis of cancer were matched (1:1) to cancer-free controls by age and sex in 2 separate matched cohorts based on the absence (matched cohort 1) or presence (matched cohort 2) of prior ischemic stroke. The primary outcome was the incidence of ischemic stroke. We calculated subdistribution adjusted hazard ratios (aHR) and 95% CIs for ischemic stroke (death as a competing event).

Results

In matched cohort 1, the rate and risk of ischemic stroke were higher among 620,647 patients with cancer versus 620,647 controls at 1.5 years (4.6/1000 person-years [95% CI, 4.5-4.7] vs 3.5/1000 person-years [95% CI, 3.4-3.6]; aHR, 1.40; 95% CI, 1.34-1.47). In matched cohort 2, the rate and risk of ischemic stroke were similar among 13,924 patients with cancer and 13,924 controls at 1.5 years (26.9/1000 person-years [95%CI 25.1-28.9] vs 22.0 /1000 person-years [95% CI, 20.7-23.4]; aHR, 1.00; 95% CI, 0.88-1.14). In both cohorts, the risk of ischemic stroke was lower in patients with cancer versus controls from 1.5 to 5 years (aHR, 0.72; 95% CI, 0.69-0.74 and aHR, 0.53; 95% CI, 0.46-0.62).

Conclusions

Compared with cancer-free controls, the rate and risk of ischemic stroke were higher 1.5 years after cancer diagnosis in individuals without prior stroke and varied according to cancer site and stage.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症诊断后缺血性卒中的风险:一项基于人群的匹配队列研究
背景:关于癌症与缺血性脑卒中之间关系的数据有限,尤其是在既往有脑卒中的人群中。我们的目标是测量并比较癌症患者和非癌症患者发生缺血性中风的风险:方法:在加拿大安大略省开展基于人群的匹配队列研究。在两个独立的匹配队列中,年龄≥18 岁、新诊断为癌症的参与者与无癌症对照者按年龄和性别进行了匹配(1:1),匹配的依据是既往无缺血性中风(匹配队列 1)或既往有缺血性中风(匹配队列 2)。主要结果是缺血性中风的发病率。我们计算了缺血性中风(死亡为竞争事件)的亚分布调整危险比(aHR)和 95% 置信区间(CI):在匹配队列 1 中,620 647 名癌症患者与 620 647 名对照组相比,1.5 年后缺血性中风的发生率和风险更高(4.6/1000 人年 [95%CI 4.5-4.7] vs 3.5/1000 人年 [95%CI 3.4-3.6],aHR 1.40,95%CI 1.34-1.47)。在匹配队列 2 中,13924 名癌症患者和 13924 名对照者在 1.5 年时发生缺血性中风的比例和风险相似(26.9/1000 人-年 [95%CI 25.1-28.9] vs 22.0 /1000 人-年 [95/%CI 20.7-23.4]; aHR 1.00, 95%CI 0.88-1.14)。在两个队列中,癌症患者在1.5至5年内发生缺血性中风的风险均低于对照组(aHR 0.72,95%CI 0.69-0.74;aHR 0.53,95%CI 0.46-0.62):结论:与未患癌症的对照组相比,既往未发生过中风的癌症患者在确诊癌症后 1.5 年发生缺血性中风的比例和风险较高,且因癌症部位和分期而异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis 医学-外周血管病
CiteScore
24.30
自引率
3.80%
发文量
321
审稿时长
1 months
期刊介绍: The Journal of Thrombosis and Haemostasis (JTH) serves as the official journal of the International Society on Thrombosis and Haemostasis. It is dedicated to advancing science related to thrombosis, bleeding disorders, and vascular biology through the dissemination and exchange of information and ideas within the global research community. Types of Publications: The journal publishes a variety of content, including: Original research reports State-of-the-art reviews Brief reports Case reports Invited commentaries on publications in the Journal Forum articles Correspondence Announcements Scope of Contributions: Editors invite contributions from both fundamental and clinical domains. These include: Basic manuscripts on blood coagulation and fibrinolysis Studies on proteins and reactions related to thrombosis and haemostasis Research on blood platelets and their interactions with other biological systems, such as the vessel wall, blood cells, and invading organisms Clinical manuscripts covering various topics including venous thrombosis, arterial disease, hemophilia, bleeding disorders, and platelet diseases Clinical manuscripts may encompass etiology, diagnostics, prognosis, prevention, and treatment strategies.
期刊最新文献
Sphingosine-1-phosphate regulates platelet fibrinogen binding via sphingosine-1-phosphate receptor type 4. Components of metabolic syndrome affect COVID-19 outcomes via platelet aggregation. Erratum to '2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase-based antiphospholipid antibody domain-collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non-enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies': [Journal of Thrombosis and Haemostasis. Volume 23, Issue 1, January 2025, Pages 341-344]. Differential benefits of cold-stored and room-temperature platelets in bleeding trauma patients. Prevention and treatment of thrombosis in patients with decompensated cirrhosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1